

Preparing video
Blair Vega Norfolk from Biome Australia (ASX: BIO) shares that their brand, Activated Probiotics, is thriving. Amid turbulent markets, the brand gains traction due to its focus on health outcomes and clinical backing. Blair emphasises the importance of same-store sales growth.
Blair mentions Biome’s distribution strategy, highlighting their reach across 6,000 points in Australia. With a blend of pharmacies and independent professionals, they continue to expand. Internationally, they target New Zealand, UK, Ireland, and Canada, while monitoring the US political scene.
With manufacturing in Italy and Australia, Biome avoids US supply chain issues. Ending the financial year on a high note, Blair reports Biome expects its fifth consecutive quarter of positive EBITDA and a strong cash position.